Loading company…
Portrai uses spatial transcriptomics to support biopharma target discovery and therapeutic development.
Portrai develops spatial transcriptomics tools and data for biopharma target discovery and therapeutic research. Its database contains over 2,000 patient samples and more than 50 million spatially resolved cells from solid tumors. Founded in 2021, the company is based in Seoul, South Korea. In December 2025, it raised KRW 14.5 billion in Series B funding from investors including STIC Ventures and BNH Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in